↓ Skip to main content

Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults

Overview of attention for article published in Frontiers in immunology, October 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
7 X users
reddit
1 Redditor

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults
Published in
Frontiers in immunology, October 2023
DOI 10.3389/fimmu.2023.1263926
Pubmed ID
Authors

Reinaldo S. Dos Santos, Daniel Guzman-Llorens, Atenea A. Perez-Serna, Angel Nadal, Laura Marroqui

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 15%
Student > Ph. D. Student 1 8%
Student > Bachelor 1 8%
Student > Doctoral Student 1 8%
Unknown 8 62%
Readers by discipline Count As %
Medicine and Dentistry 2 15%
Biochemistry, Genetics and Molecular Biology 1 8%
Social Sciences 1 8%
Immunology and Microbiology 1 8%
Unknown 8 62%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2023.
All research outputs
#7,904,924
of 25,394,764 outputs
Outputs from Frontiers in immunology
#9,367
of 31,549 outputs
Outputs of similar age
#113,785
of 354,949 outputs
Outputs of similar age from Frontiers in immunology
#194
of 1,182 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 31,549 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,949 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 1,182 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.